EpilepsyEMO-INTRANCT07544563
Phenotypic Exploration During Sensory Stimulation in an Acoustic Chamber
An observational study of Epilepsy and Anxiety, run by Centre Hospitalier St Anne at 1 site in France.
Trial summary
An observational behavioural and neurophysiological study of the effects of controlled sensory stimulation (such as music, for example) on brain function Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Epilepsy, Anxiety, Depression Anxiety Disorder
- How many people
- 320 participants
- Where
- 1 siteFrance
- Study dates
- 2 Dec 2025to 2 Dec 2035
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Study population: GHU paris Sainte Anne
Who may be able to join
- For patients : epilepsy
- For healthy volunteers: age > 18 yo
Who cannot join
- For patients and healthy volonteers : Deafness
- For healthy volunteers : History of neurological conditions (including stroke, coma, epilepsy, neuro-inflammatory or neurodegenerative disease) or diagnosed cognitive impairment
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
France1 site, 1 recruiting
- Recruiting
GHU Paris Sainte Anne
Paris, 75014
Estelle Pruvost-Robieux, MD, PHD, +33145658189, e.pruvost@ghu-paris.fr
Estelle Pruvost-Robieux, MD, PHD
About this study
Official title: Exploration phénotypique en Contexte de Stimulations Sensorielles en Chambre Acoustique
An observational behavioural and neurophysiological study of the effects of controlled sensory stimulation (such as music, for example) on brain function
- Conditions
- Epilepsy, Anxiety, Depression Anxiety Disorder
- Medical subject headings
- Epilepsy, Anxiety Disorders
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| Epilepsy and music | Epileptic patients (with or without mood disorders) exposed to music stimulations |
What is being measured
The primary outcome is the main question the study is designed to answer.
Neuronal networks
Description of the neural networks involved during exposure to sensory stimuli
Measured: All along the study (8 years)
Secondary outcomes (3)
Psychologic outcome : anxiety
Assessment of the Generalized Anxiety Disorder-7 (GAD7) in the exposed patients across the hospitalization :
minimum value 0; maximum 21; higher scores mean a worse outcome
Measured: 8 years
Psychologic outcome 2 : depression
Assessment of the Neurological Disorders Depression Inventory for Epilepsy (NDDI-E) in the exposed patients across the hospitalization : minimum value 6; maximum 24; higher scores mean a worse outcome
Measured: 8 years
Quality of life measure
Assessment of the QOLIE-31(quality of life in epilepsy) scale among exposed patients
Measured: 8 years
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted22 Apr 2026
- Study start2 Dec 2025
- Primary completion2 Dec 2035 (estimated)
- Study completion2 Dec 2035 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for EpilepsyStudies of the same condition, open and under way.
- More trials run by Centre Hospitalier St AnneThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 320 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Centre Hospitalier St Anne
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07544563
- Sponsor's protocol ID
- D25-P008
- Acronym
- EMO-INTRA
- Status last verified
- Apr 2026
- First submitted
- 3 Apr 2026
- Last updated
- 22 Apr 2026
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 22 Apr 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Exploration phénotypique en Contexte de Stimulations Sensorielles en Chambre Acoustique
- ClinicalTrials.gov ID
- NCT07544563
- Acronym / sponsor ID
- EMO-INTRA / D25-P008
- Conditions
- Epilepsy, Anxiety, Depression Anxiety Disorder
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 320 participants (estimated)
- Lead sponsor
- Centre Hospitalier St AnneUniversity, hospital or other
- Study start
- 2 Dec 2025 (actual)
- Primary completion
- 2 Dec 2035 (estimated)
- Study completion
- 2 Dec 2035 (estimated)
- First posted
- 22 Apr 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
An observational behavioural and neurophysiological study of the effects of controlled sensory stimulation (such as music, for example) on brain function
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Epilepsy and music | – | –Epileptic patients (with or without mood disorders) exposed to music stimulations |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
- Study population
- GHU paris Sainte Anne
Key inclusion criteria (2 listed)
- For patients : epilepsy
- For healthy volunteers: age > 18 yo
Key exclusion criteria (2 listed)
- For patients and healthy volonteers : Deafness
- For healthy volunteers : History of neurological conditions (including stroke, coma, epilepsy, neuro-inflammatory or neurodegenerative disease) or diagnosed cognitive impairment
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Neuronal networks
Time frame: All along the study (8 years)
Description of the neural networks involved during exposure to sensory stimuli
3 secondary outcomes
Psychologic outcome : anxiety
Time frame: 8 years
Psychologic outcome 2 : depression
Time frame: 8 years
Quality of life measure
Time frame: 8 years
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 22 Apr 2026.
Related trials for Epilepsy
Not yet recruiting
Clinical Trial of SEEG for Drug-resistant Epilepsy
Drug-Resistant Epilepsy
RecruitingPhase 3
Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and Adults
Seizures, Lennox Gastaut Syndrome
RecruitingPhase 3
Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures
Focal Seizure, Epilepsy
Active, not recruitingObservational study
Transforming Research and Clinical Knowledge in Traumatic Brain Injury Epileptogenesis Project (TRACK-TBI EPI)
Traumatic Brain Injury, Post-traumatic Epilepsy
RecruitingPhase 3
Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures FOCUS-1
Focal Seizure, Epilepsy
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Epilepsy and Anxiety, run by Centre Hospitalier St Anne at 1 site in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 22 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Viviane AWASSI (+33145658486, v.awassi@ghu-paris.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Neuronal networks (time frame: All along the study (8 years)). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Apr 2026.